Qian; XiaoXia

Patent Applications and Registrations

Patent applications and USPTO patent grants for Qian; XiaoXia.The latest application filed is for "pyrimidinone amide compounds as pde2 inhibitors".

Company Profile

1.27.25

Qian; XiaoXia - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrimidinone amide compounds as PDE2 inhibitors Grant 10,285,989 - Shen , et al.	2019-05-14
Pyrimidinone Amide Compounds As Pde2 Inhibitors App 20180256575 - Shen; Dong-Ming ; et al.	2018-09-13
Azabenzimidazole tetrahydrofuran derivatives Grant 9,868,733 - Apgar , et al. January 16, 2	2018-01-16
Pyrimidone carboxamide compounds as PDE2 inhibitors Grant 9,815,796 - Shen , et al. November 14, 2	2017-11-14
Spirocyclic CETP inhibitors Grant 9,717,714 - Ondeyka , et al. August 1, 2	2017-08-01
Benzimidazole hexahydrofuro[3,2-b]furan derivatives Grant 9,556,193 - Apgar , et al. January 31, 2	2017-01-31
Pyrimidone Carboxamide Compounds As Pde2 Inhibitors App 20170015633 - Shen; Dong Ming ; et al.	2017-01-19
Benzimidazole tetrahydrofuran derivatives Grant 9,540,364 - Apgar , et al. January 10, 2	2017-01-10
Benzimidazole tetrahydropyran derivatives Grant 9,527,839 - Apgar , et al. December 27, 2	2016-12-27
Azabenzimidazole tetrahydropyran derivatives Grant 9,382,243 - Apgar , et al. July 5, 2	2016-07-05
Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives Grant 9,290,517 - Apgar , et al. March 22, 2	2016-03-22
Cyclic amine substituted oxazolidinone CETP inhibitor Grant 9,221,834 - Lu , et al. December 29, 2	2015-12-29
Spirocyclic Cetp Inhibitors App 20150342931 - Ondeyka; Debra ; et al.	2015-12-03
Novel Azabenzimidazole Hexahydrofuro[e,2-b]furan Derivatives App 20150284411 - Apgar; James M. ; et al.	2015-10-08
Novel Benzimidazole Tetrahydrofuran Derivatives App 20150218149 - Apgar; James M. ; et al.	2015-08-06
Novel Benzimidazole Hexahydrofuro[3,2-b]furan Derivatives App 20150218183 - Apgar; James M. ; et al.	2015-08-06
Novel Azabenzimidazole Tetrahydropyran Derivatives App 20150210685 - Apgar; James M. ; et al.	2015-07-30
Novel Azabenzimidazole Tetrahydrofuran Derivatives App 20150203487 - Apgar; James M. ; et al.	2015-07-23
Novel Benzimidazole Tetrahydropyran Derivatives App 20150197516 - Apgar; James M. ; et al.	2015-07-16
Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes Grant 8,980,929 - Hicks , et al. March 17, 2	2015-03-17
Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes Grant 8,853,212 - Wilkening , et al. October 7, 2	2014-10-07
Cyclic azabenzimidazole derivatives useful as anti-diabetic agents Grant 8,796,258 - Anand , et al. August 5, 2	2014-08-05
Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 8,653,059 - Biftu , et al. February 18, 2	2014-02-18
Cyclic Amine Substituted Oxazolidinone CETP Inhibitor App 20130331372 - Lu; Zhijian ; et al.	2013-12-12
Substituted Seven-membered Heterocyclic Compounds As Dipeptidyl Peptidase-iv Inhibitors For The Treatment Of Diabetes App 20130203786 - Hicks; Jacqueline D. ; et al.	2013-08-08
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 8,455,533 - Biftu , et al. June 4, 2	2013-06-04
Novel Cyclic Azabenzimidazole Derivatives Useful As Anti-diabetic Agents App 20130123237 - Anand; Rajan ; et al.	2013-05-16
Substituted Aminotetrahydrothiopyrans And Derivatives Thereof As Dipeptidyl Peptidase-iv Inhibitors For The Treatment Of Diabetes App 20120277240 - Wilkening; Robert R. ; et al.	2012-11-01
Aminotetrahydropyrans As Dipeptidyl Peptidase-iv Inhibitors For The Treatment Or Prevention Of Diabetes App 20120149734 - Biftu; Tesfaye ; et al.	2012-06-14
Heterocyclic Compounds As Dipeptidyl Peptidase-iv Inhibitors For The Treatment Or Prevention Of Diabetes App 20110224195 - Biftu; Tesfaye ; et al.	2011-09-15
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 7,910,596 - Biftu , et al. March 22, 2	2011-03-22
Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes Grant 7,906,649 - Biftu , et al. March 15, 2	2011-03-15
Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes App 20100234403 - Biftu; Tesfaye ; et al.	2010-09-16
Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 7,750,034 - Biftu , et al. July 6, 2	2010-07-06
Aminocyclohexanes as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes App 20090270467 - Biftu; Tesfaye ; et al.	2009-10-29
3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 7,560,455 - Biftu , et al. July 14, 2	2009-07-14
Aminocyclohexanes as Dipeptidyl Peptidase-IV for the Treatment or Prevention of Diabetes App 20090105284 - Biftu; Tesfaye ; et al.	2009-04-23
(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds Grant 7,196,095 - Biftu , et al. March 27, 2	2007-03-27
3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20060258646 - Biftu; Tesfaye ; et al.	2006-11-16
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 7,101,871 - Biftu , et al. September 5, 2	2006-09-05
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20040254167 - Biftu, Tesfaye ; et al.	2004-12-16
(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds App 20040176396 - Biftu, Tesfaye ; et al.	2004-09-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.